Form 4: Nautilus Biotechnology CEO Sujal Patel Increases Stake in Company
SEC Form 4
Nautilus Biotechnology CEO Sujal M. Patel has been actively purchasing company stock, increasing his direct and indirect holdings.
Summary
- On March 5, 2024, Sujal M. Patel, the CEO, President, and Secretary of Nautilus Biotechnology, acquired 7,405 shares of common stock at a weighted average price of $2.6464.
- On March 6, 2024, Patel acquired an additional 9,267 shares at a weighted average price of $2.7014.
- On March 7, 2024, Patel further increased his holdings by purchasing 18,854 shares at a weighted average price of $2.8866.
- Following these transactions, Patel directly owns 10,050,014 shares of Nautilus Biotechnology common stock.
- Patel also indirectly owns 1,814,035 shares through the Sujal Patel 2020 Children's Trust and 5,280,476 shares through PFV I, LLC.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive due to the CEO's increased investment in the company, which suggests confidence in its future. However, it's important to consider this in the context of the company's overall performance and industry trends.
Positives
- The CEO's purchase of shares may signal confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company's leadership believes the stock is undervalued. However, it's important to consider the overall context of the company's performance and industry trends.
Stakeholder Impact
- Shareholders may view the CEO's stock purchases as a positive signal.
- The increased stake of the CEO aligns his interests more closely with those of other shareholders.
Key Dates
| Date | Description |
|---|---|
| December 3, 2020 | Date of Sujal Patel 2020 Children's Trust agreement (u/a/d) |
| 03/05/2024 | Date of first reported transaction: purchase of 7,405 shares |
| 03/06/2024 | Date of second reported transaction: purchase of 9,267 shares |
| 03/07/2024 | Date of third reported transaction: purchase of 18,854 shares and filing date of the Form 4 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.